Pronoxis
Pre-clinicalProNoxis specialises in the preclinical exploration of small-molecule medications for the treatment of chronic inflammatory, autoimmune, and infectious conditions.
Founded
2009
Focus
Small Molecules
About
ProNoxis specialises in the preclinical exploration of small-molecule medications for the treatment of chronic inflammatory, autoimmune, and infectious conditions.
Company Info
TypePrivate
Founded2009
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile